Xiang Xue
Julie In
Hua Geng
Ying Xiao
Zhangfa Song- 1Department of Biochemistry and Molecular Biology, School of Medicine, University of New Mexico, Albuquerque, NM, United States
- 2Division of Gastroenterology, Department of Internal Medicine, School of Medicine, University of New Mexico, Albuquerque, NM, United States
- 3Ann and Robert H. Lurie Children’s Hospital of Chicago, Department of Pediatrics, Northwestern University, Chicago, IL, United States
- 4Department of Colorectal Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China
Editorial on the Research Topic
The Use of Organoids in Cancer Biology
Cancer is a major public health problem worldwide and the second leading cause of death in the United States (Siegel et al., 2022). Despite the advance in medicine, there is still no therapeutic that can cure advanced cancer. Thus, better therapeutic approaches are urgently needed for targeting cancer cells. Organoids are an emerging research tool in stem cell biology, regenerative medicine, virology, and cancer biology. This editorial article frames the aim of this Research Topic as to gather promising, recent, and novel research trends in the organoids towards cancer biology field.
There are two approaches to establish organoids. The first approach was developed by the Hans Clevers’ group. They established the long-term culture conditions for self-organizing crypt-villus structures named organoids that proliferate in vitro without a mesenchymal niche (Sato et al., 2009). These organoids are generated from single sorted Lgr5 (+) stem cells isolated from crypts obtained from adult donors (Sato et al., 2009). The second approach was developed by the James Wells’ group. They successfully differentiated human embryonic and induced pluripotent stem cells (iPSCs) into three-dimensional intestinal ‘organoids’ in vitro (Spence et al., 2011). These iPSC organoids are also surrounded by mesenchymal cells that secrete factors found in the mesenchymal niche. Both approaches are used by researchers, but the first approach is more easily applicable for tissues from various organs, takes a shorter time to establish and the culture media has been commercialized. One of the research articles published in this Research Topic alerts us that low-level contaminating mouse DNA is present in the conditioned culture media derived from the L-WRN cell line and in human organoid cultures maintained in this media (Bohm et al., 2020). This suggests that we still need to optimize the culture conditions. Moreover, as discussed in one of the review articles published in this Research Topic (Luo et al., 2022), organoid biobanks are established at both academic institutes (Bender, 2015), and nonprofit organizations such as American Type Culture Collection (ATCC).
Organoids are highly physiologically relevant models and appear as an ideal system to recapitulate many of the central aspects of tumor microenvironment including, but not limited to, 3D morphology and polarized expression of differentiation and stem cell markers. Many such markers are lost in established cell lines. Furthermore, tumor organoids can be genetically engineered using virus-mediated gene delivery or generated from genetically modified animals. Importantly, a subset of the patient-derived organoids can be grown in minimally supplemented serum-free media, which is desirable for experimental interrogations such as nutrient supplementation. Recent developed the long-term homeostatic culture of tubular mini-guts which overcomes the limitation of traditional 3D organoids developing tissues with a closed, cystic architecture that restricts lifespan and size, makes the organoids can be experimental manipulated and prolong its homeostasis (Nikolaev et al., 2020).
Human colon organoids are useful for both physiologic and pathophysiologic studies, because they are a tractable intestinal epithelia model that better mimic the gut compared to cell lines. Importantly, it has been observed that epithelial-produced WNT2B is essential for colonic regeneration and works with the Hedgehog pathway in human organoids (In et al., 2020). This partly explains the contribution of Wnt and Hedgehog signaling in injury-induced colonic regeneration and in the initiation steps of left-sided colorectal cancer. Moreover, iron is required for sustaining nucleotide metabolism and mitochondrial function in patient-derived colorectal cancer organoids (Schwartz et al., 2021). Consistently, pharmacological inhibition of iron uptake transporter divalent metal transporter 1 (DMT1) reduces tumor growth and cell proliferation of patient-derived colorectal cancer organoids in vitro and in an orthotopic transplantation mouse model (Xue et al., 2016).
Metastasis is the primary cause of morbidity and mortality in cancer patients. Investigators have developed sophisticated genetic engineered mouse models to recapture tumor progression and metastasis (Tauriello et al., 2018). However, the breeding protocol is arduous and is not cost-effective. Alternatively, tumor organoids derived from these mouse models have been established to study metastasis within a few weeks. Orthotopic transplantation models of CRISPR-Cas9-edited mouse organoids and patient-derived organoids have also been established with efficient and rapid metastatic tumor formation (Roper et al., 2017).
Patient-derived tumor organoids can faithfully recapitulate many characteristics of in vivo tumors. This has enabled the determination of individualized drug responses through organoid screening (Toshimitsu et al., 2022). One of the research articles published in this Research Topic investigated the effects of a multi-mineral natural product on colonic barrier in colonoids and suggested that adequate mineral intake might improve the colonic barrier (Aslam et al., 2020). More and more researchers are also using 3D-organoids-derived monolayer culture for drug screening and other experiments (Kozuka et al., 2017). Furthermore, the baseline properties of tumor organoids predict immunological response to PD-1 inhibition (Voabil et al., 2021), thus facilitating immunotherapy.
In Summary, organoids are a promising and powerful research tool in oncology research. As discussed in one of the review articles published in this Research Topic (Yang et al., 2021), there are still challenges and limitations in organoids application, but with the advanced bioengineering techniques such as 3D Bioprinting and Organoid-on-a-Chip, we expect a common use of organoids in clinical application will be realized in the near future.
Author Contributions
XX wrote the manuscript, JI, HG, YX and ZS edited the manuscript.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Acknowledgments
XX was supported in part by the National Institutes of Health (P20 GM130422) and a Research Scholar Grant from the American Cancer Society (RSG-18-050-01-NEC).
References
Aslam, M. N., McClintock, S. D., Attili, D., Pandya, S., Rehman, H., Nadeem, D. M., et al. (2020). Ulcerative Colitis-Derived Colonoid Culture: A Multi-Mineral-Approach to Improve Barrier Protein Expression. Front. Cell Dev. Biol. 8, 577221. doi:10.3389/fcell.2020.577221
Bohm, M. S., Dame, M. K., Boyd, J., Su, K., Wu, A., Attili, D., et al. (2020). Low-Level Mouse DNA in Conditioned Medium Generates False Positive Cross-Species Contamination Results in Human Organoid Cultures. Front. Cell Dev. Biol. 8, 587107. doi:10.3389/fcell.2020.587107
In, J. G., Yin, J., Atanga, R., Doucet, M., Cole, R. N., and DeVine, L., (2020). Epithelial WNT2B and Desert Hedgehog Are Necessary for Human Colonoid Regeneration after Bacterial Cytotoxin Injury. IScience 23, 101618. doi:10.1016/j.isci.2020.101618
Kozuka, K., He, Y., Koo-McCoy, S., Kumaraswamy, P., Nie, B., Shaw, K., et al. (2017). Development and Characterization of a Human and Mouse Intestinal Epithelial Cell Monolayer Platform. Stem Cell Rep. 9 (6), 1976–1990. doi:10.1016/j.stemcr.2017.10.013
Luo, L., Ma, Y., Zheng, Y., Su, J., and Huang, G. (2022). Application Progress of Organoids in Colorectal Cancer. Front. Cell Dev. Biol. 10. 815067. doi:10.3389/fcell.2022.815067
Nikolaev, M., Mitrofanova, O., Broguiere, N., Geraldo, S., Dutta, D., Tabata, Y., et al. (2020). Homeostatic Mini-Intestines through Scaffold-Guided Organoid Morphogenesis. Nature 585 (7826), 574–578. doi:10.1038/s41586-020-2724-8
Roper, J., Tammela, T., Cetinbas, N. M., Akkad, A., Roghanian, A., Rickelt, S., et al. (2017). In Vivo genome Editing and Organoid Transplantation Models of Colorectal Cancer and Metastasis. Nat. Biotechnol. 35 (6), 569–576. doi:10.1038/nbt.3836
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., et al. (2009). Single Lgr5 Stem Cells Build Crypt-Villus Structures In Vitro without a Mesenchymal Niche. Nature 459 (7244), 262–265. doi:10.1038/nature07935
Schwartz, A. J., Goyert, J. W., Solanki, S., Kerk, S. A., Chen, B., Castillo, C., et al. (2021). Hepcidin Sequesters Iron to Sustain Nucleotide Metabolism and Mitochondrial Function in Colorectal Cancer Epithelial Cells. Nat. Metab. 3 (7), 969–982. doi:10.1038/s42255-021-00406-7
Siegel, R. L., Miller, K. D., Fuchs, H. E., and Jemal, A. (2022). Cancer Statistics, 2022. CA A Cancer J. Clin. 72 (1), 7–33. doi:10.3322/caac.21708
Spence, J. R., Mayhew, C. N., Rankin, S. A., Kuhar, M. F., Vallance, J. E., Tolle, K., et al. (2011). Directed Differentiation of Human Pluripotent Stem Cells into Intestinal Tissue In Vitro. Nature 470 (7332), 105–109. doi:10.1038/nature09691
Tauriello, D. V. F., Palomo-Ponce, S., Stork, D., Berenguer-Llergo, A., Badia-Ramentol, J., Iglesias, M., et al. (2018). TGFβ Drives Immune Evasion in Genetically Reconstituted Colon Cancer Metastasis. Nature 554 (7693), 538–543. doi:10.1038/nature25492
Toshimitsu, K., Takano, A., Fujii, M., Togasaki, K., Matano, M., Takahashi, S., et al. (2022). Organoid Screening Reveals Epigenetic Vulnerabilities in Human Colorectal Cancer. Nat. Chem. Biol. 18(6), 605–614. doi:10.1038/s41589-022-00984-x
Voabil, P., de Bruijn, M., Roelofsen, L. M., Hendriks, S. H., Brokamp, S., van den Braber, M., et al. (2021). An Ex Vivo Tumor Fragment Platform to Dissect Response to PD-1 Blockade in Cancer. Nat. Med. 27 (7), 1250–1261. doi:10.1038/s41591-021-01398-3
Xue, X., Ramakrishnan, S. K., Weisz, K., Triner, D., Xie, L., Attili, D., et al. (2016). Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal Tumorigenesis. Cell Metab. 24 (3), 447–461. doi:10.1016/j.cmet.2016.07.015
Keywords: organoids, cancer, biobank, metastasis, therapy
Citation: Xue X, In J, Geng H, Xiao Y and Song Z (2022) Editorial: The Use of Organoids in Cancer Biology. Front. Cell Dev. Biol. 10:948926. doi: 10.3389/fcell.2022.948926
Received: 20 May 2022; Accepted: 16 June 2022;
Published: 07 July 2022.
Edited and reviewed by:
Valerie Kouskoff, The University of Manchester, United KingdomCopyright © 2022 Xue, In, Geng, Xiao and Song. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xiang Xue, eHh1ZUBzYWx1ZC51bm0uZWR1